BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 1937083)

  • 1. Histopathology studies in human malignant melanomas of the choroid after unsuccessful treatment with 106Ru/106Rh ophthalmic applicators.
    Klaus H; Lommatzsch PK; Fuchs U
    Graefes Arch Clin Exp Ophthalmol; 1991; 229(5):480-6. PubMed ID: 1937083
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fluorescein angiography in the follow-up study of choroidal melanoma after 106Ru/106Rh plaque therapy.
    Lommatzsch PK; Ballin RE; Helm W
    Retina; 1987; 7(3):148-55. PubMed ID: 3423430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 106Ru/106Rh plaque radiotherapy for malignant melanomas of the choroid. With follow-up results more than 5 years.
    Lommatzsch PK; Kirsch IH
    Doc Ophthalmol; 1988; 68(3-4):225-38. PubMed ID: 3402313
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Optimization of irradiation time in the treatment of malignant melanoma of the choroid with beta applicators (106Ru/106Rh)].
    Lommatzsch PK; Weise B; Ballin R
    Klin Monbl Augenheilkd; 1986 Aug; 189(2):133-40. PubMed ID: 3761990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
    Lommatzsch PK
    Trans Ophthalmol Soc U K (1962); 1977 Sep; 97(3):428-9. PubMed ID: 274003
    [No Abstract]   [Full Text] [Related]  

  • 6. [Echocardiography findings before and following beta-irradiation (106Ru/106Rh) of choroid melanoma].
    Eichler C; Hertel A; Lommatzsch PK; Fuhrmann P
    Klin Monbl Augenheilkd; 1987 Jan; 190(1):17-20. PubMed ID: 3573649
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Radiation retinopathy following treatment of choroid melanomas with 106Ru/106Rh applicators].
    Foerster MH; Fried M; Wessing A; Meyer-Schwickerath G
    Fortschr Ophthalmol; 1983; 80(5):418-21. PubMed ID: 6642368
    [No Abstract]   [Full Text] [Related]  

  • 8. Techniques and results of 106Ru/106Rh radiation of choroidal tumours.
    Busse H; Müller RP
    Trans Ophthalmol Soc U K (1962); 1983; 103 ( Pt 1)():72-7. PubMed ID: 6581639
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of choroidal melanomas with 106Ru/106Rh beta-ray applicators.
    Lommatzsch P
    Surv Ophthalmol; 1974; 19(2):85-100. PubMed ID: 4612808
    [No Abstract]   [Full Text] [Related]  

  • 10. Radiation effects on the optic nerve observed after brachytherapy of choroidal melanomas with 106Ru/106Rh plaques.
    Lommatzsch PK; Alberti W; Lommatzsch R; Rohrwacher F
    Graefes Arch Clin Exp Ophthalmol; 1994 Aug; 232(8):482-7. PubMed ID: 7926883
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Experiences in the treatment of malignant melanoma of the choroid with 106Ru-106Rh beta-ray applicators.
    Lommatzsch PK
    Trans Ophthalmol Soc U K (1962); 1973; 93(0):119-32. PubMed ID: 4526435
    [No Abstract]   [Full Text] [Related]  

  • 12. Indocyanine green angiography versus fluorescein angiography in the follow-up of choroidal melanomas treated with RU106/RH106.
    Sallet G; Amoaku WM; Lafaut BA; Van Liefferinge B; De Laey JJ
    Bull Soc Belge Ophtalmol; 1996; 263():27-37. PubMed ID: 9396191
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Results after beta-irradiation (106Ru/106Rh) of choroidal melanomas. Twenty years' experience.
    Lommatzsch PK
    Am J Clin Oncol; 1987 Apr; 10(2):146-51. PubMed ID: 3565313
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative duplex and color Doppler ultrasound in the follow-up of beta-irradiated (106Ru/106Rh) choroidal melanomas. A prospective study.
    Wolff-Kormann PG; Kormann BA; Riedel KG; Hasenfratz GC; Spengel FA
    Ger J Ophthalmol; 1992; 1(3-4):151-5. PubMed ID: 1483127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. beta-Irradiation of choroidal melanoma with 106Ru/106Rh applicators. 16 Years' experience.
    Lommatzsch PK
    Arch Ophthalmol; 1983 May; 101(5):713-7. PubMed ID: 6847458
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Treatment of various malignant melanomas of the choroid using a combination of ruthenium 106 and cobalt 60].
    Bacin F; Rozan R; Donnarieix D; Dalens H
    Ophtalmologie; 1990; 4(3):225-8. PubMed ID: 2250952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Complications of the irradiation therapy with beta applicators in malign melanomas (author's transl)].
    Hallermann D
    Klin Monbl Augenheilkd; 1979 Jun; 174(6):982-4. PubMed ID: 480853
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Treatment of bilateral choroidal malignant melanoma.
    Lommatzsch PK; Hallermann D; von Domarus D
    Dev Ophthalmol; 1981; 2():105-13. PubMed ID: 7262390
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A histologic study (including DNA quantification and Ki-67 labeling index) in uveal melanomas after brachytherapy with ruthenium plaques.
    Schilling H; Sehu KW; Lee WR
    Invest Ophthalmol Vis Sci; 1997 Sep; 38(10):2081-92. PubMed ID: 9331272
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ruthenium applicators in the treatment of choroidal melanomas.
    Van Hijfte R; Verbraeken H; De Laey JJ
    Bull Soc Belge Ophtalmol; 1987; 224():51-8. PubMed ID: 3509023
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.